tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder
Key facts
- Who runs it
- Centre Hospitalier Henri Laborit
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 17 Oct 2023
- Expected to end
- Jul 2027
- Type of study
- Interventional
- Treatments tested
- tDCS + symptoms provocation
- Record updated
- 23 October 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Patient suffering from OCD evolving for at least 2 years diagnosed according to DSM-V criteria
- Patient with good insight, defined by a score less than or equal to 18 at the threshold of delusions on the BABS (Brown Assessment of Beliefs Scale) insight scale
- Absence of a current depressive episode (MADRS score < 21) or suicidal risk (MADRS score item 10 < 3)
- Absence of epileptic pathology
- Chronic obsessive-compulsive disorder defined by a total YBOCS score > 20, or a subscale score > 15
- Drug-resistant obsessive-compulsive disorder despite treatment with:; at least 2 antidepressants of the IRS type at an effective dose and for a sufficient duration; and/or Behavioral and Cognitive therapy for at least 1 year
- Therapeutic stability (antidepressants) for more than 12 weeks without significant improvement. This treatment, at a fixed dose, will be maintained during the study
- Patient aged between 18 and 70 included
- Patient who has given his/her informed consent after having received written information on the planned procedure
- Patient benefiting from social security or by benefiting through a third party
Who cannot take part
- Patient with another DSM-V Axis 1 diagnosis (Schizophrenic Disorder, Bipolar Disorder, Substance Abuse or Substance Dependence); Generalized anxiety disorder, social phobia, nicotine addiction and history of major depressive episodes are not exclusion criteria. Axis I comorbidity will be explored using MINI 5.0.0.
- History of head trauma
- Woman of childbearing age without effective means of contraception (hormonal/mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)
- Pregnant or nursing woman
- Patient hospitalized under duress (SPDT, SPDRE)
- Patient under guardianship or curatorship
- Patient suffering from a current depressive episode
- Patient at risk of suicide
- Patient with skin lesions on the scalp
- Patient with an intracerebral metal object
- Patient with a pacemaker
- Presence of epileptic pathology
- Patient in an emergency situation or unable to give personal consent
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a single-center study about patients with severe resistant OCD.
Read full original descriptionShow less
Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex, and the cathode at the level of the supplementary motor area, associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms.
After the inclusion visit, the treatment period is provided from D1 to D12 (one session per day from Monday to Friday, for two consecutive weeks, i.e. a total of ten sessions). Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel.
The patients are then assessed on D42 and D102 (i.e. 1 month and 3 months after the end of the tDCS sessions).
The group in the trial
- tDCS + symptoms provocationTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Direct Transcranial Stimulation With Direct Current Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive
- Criteria questions
- Built from NCT06017713, who can take part
- Record updated
- 23 October 2026